Hepatocellular Carcinoma Identification Using Delta-HLD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hepatocellular Carcinoma Identification Using Delta-HLD — Stella

Recruiting

Back to Hepato Cellular Carcinoma (HCC) trials

Trial locations(1 site)

Argentina

Epiliquid, Mendoza

Key details

Sponsor

Epiliquid Holding, Inc

Enrollment target

~200 participants

Started

May 2023

Primary completion

August 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov